Skip to main content
TipRanks
Go Ultimate75% OFF

Faron Pharmaceuticals Oy (4FR) Stock Forecast & Price Target

9 Followers
See the Price Targets and Ratings of:

4FR Analyst Ratings

Moderate Buy
1Ratings
1Buy0Hold0Sell
Based on 1 analysts giving stock ratings to Faron Pharmaceuticals Oy in the past 3 months

4FR Stock 12 Month Forecast

€11.96▲(3416.48% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Faron Pharmaceuticals Oy in the last 3 months. The average price target is EUR 11.96 with a high forecast of EUR 11.96 and a low forecast of EUR 11.96. The average price target represents a 3416.48% change from the last price of EUR 0.34.
Highest Price Target€11.96Average Price Target€11.96Lowest Price Target€11.96

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:4FR
Price TargetArticle
H.C. Wainwright€11.96buy3416.48%UpsideReiterated11/04/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PLSEPulse Biosciences
SLDBSolid Biosciences
RZLTRezolute
IMUXImmunic
MDWDMediwound

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Faron Pharmaceuticals Oy

3 Months
Patrick Trucchio
Patrick TrucchioH.C. Wainwright
Success Rate3/21 ratings generated profit
14%
Average Return
-9.86%

Copying Patrick Trucchio's trades and holding each position for 3 Months would result in 14.29% of your transactions generating a profit, with an average return of -9.86% per trade.

1 Year
Patrick Trucchio
Patrick TrucchioH.C. Wainwright
Success Rate1/21 ratings generated profit
5%
Average Return
-48.17%

Copying Patrick Trucchio's trades and holding each position for 1 Year would result in 4.76% of your transactions generating a profit, with an average return of -48.17% per trade.

2 Years
Patrick Trucchio
Patrick TrucchioH.C. Wainwright
Success Rate0/21 ratings generated profit
0%
Average Return
-62.41%

Copying Patrick Trucchio's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -62.41% per trade.

4FR Analyst Recommendation Trends

01234Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for 4FR
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy44422
Buy00000
Hold00000
Sell00000
Strong Sell00000
total44422

In the current month, 4FR has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 4FR average Analyst price target in the past 3 months is 11.96.

4FR Financial Forecast

€-2€-1.25€-0.5€0.25€1Q2 2025Q2 2026Q4 2026
High€-0.04
Consensus€-0.05
Low€-0.05

4FR Earnings Forecast

Next quarter’s earnings estimate for 4FR is -EUR 0.05 with a range of -EUR 0.05 to -EUR 0.04. The previous quarter’s EPS was -EUR 0.05. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€-1€-0.5€0€0.5€1Q2 2025Q2 2026Q4 2026
High€0.00
Consensus€0.00
Low€0.00

4FR Sales Forecast

Next quarter’s sales forecast for 4FR is EUR 0 with a range of EUR 0 to EUR 0. The previous quarter’s sales results were EUR 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

4FR Stock Forecast FAQ

What is DE:4FR’s average 12-month price target, according to analysts?
Based on analyst ratings, Faron Pharmaceuticals Oy’s 12-month average price target is €11.96.
What is DE:4FR’s upside potential, based on the analysts’ average price target?
Faron Pharmaceuticals Oy has 3416.48% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Faron Pharmaceuticals Oy a Buy, Sell or Hold?
Faron Pharmaceuticals Oy has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Faron Pharmaceuticals Oy’s share price target?
The average share price target for Faron Pharmaceuticals Oy is €11.96. This is based on 1 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €11.96, and the lowest forecast is €11.96. The average share price target represents a 3416.48% increase from the current price of €0.34.
What do analysts say about Faron Pharmaceuticals Oy?
Faron Pharmaceuticals Oy’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of Faron Pharmaceuticals Oy?
To buy shares of DE:4FR, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.